Fulcrum Equity Management’s Bio-Techne TECH Stock Holding History

Fulcrum Equity Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,160	Closed	-$1.19M	–	179
2021 Q4	$1.19M	Sell	9,160 -2,220	-20%	-$272K	0.44%	59
2021 Q3	$1.38M	Sell	11,380 -5,744	-34%	-$699K	0.53%	52
2021 Q2	$1.93M	Sell	17,124 -5,084	-23%	-$535K	0.72%	45
2021 Q1	$2.12M	Buy	+22,208	New	+$2.03M	0.84%	40

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Fulcrum Equity Management's TECH Position: Q1 2022 in Review

Fulcrum Equity Management sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 9,160 shares — an estimated $1.19M sold.

Fulcrum Equity Management first reported a position in TECH in Q1 2021 and held it in 4 quarters. The position peaked at $2.12M in Q1 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

Fulcrum Equity Management reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
Fulcrum Equity Management sold 9,160 Bio-Techne shares in Q1 2022, an estimated $1.19M.
Fulcrum Equity Management first reported a position in Bio-Techne in Q1 2021 and held it in 4 quarters.
Fulcrum Equity Management's Bio-Techne position peaked at $2.12M in Q1 2021.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Fulcrum Equity Management's 13F filing for Q1 2022, filed 15 Apr 2022.